ExPH5: A Potential Drug Target Or Biomarker for Cancer (G23086)

Target Name: EXPH5

NCBI ID: G23086

EXPH5

ExPH5: A Potential Drug Target Or Biomarker for Cancer

EXPH5 (KiAA0624) is a protein that is expressed in various tissues of the human body, including the brain, heart, and liver. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues. The protein is also known to play a role in the regulation of cell survival and has been linked to a number of diseases, including cancer.

Recent studies have suggested that EXPH5 may be a drug target or biomarker for a number of diseases, including cancer. This has led to increased interest in the research of EXPH5 and its potential uses in medicine. In this article, we will explore the biology and potential uses of EXPH5, with a focus on its potential as a drug target.

The Biology of EXPH5

EXPH5 is a member of the TGF-β signaling pathway, which is a well-established mechanism for regulating cell growth and differentiation. The TGF-β pathway is a complex system that involves the interaction of a number of proteins, including EXPH5. This protein is involved in the regulation of cell proliferation, differentiation, and survival.

EXPH5 is a 21-kDa protein that is expressed in a variety of tissues, including the brain, heart, and liver. It is highly conserved, with a calculated pI of 5.5 and a predicted hydrophobicity of 0.42. EXPH5 is associated with a number of cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of cell survival and has been linked to a number of diseases, including cancer.

Potential Applications of EXPH5

EXPH5 has been suggested as a potential drug target or biomarker for a number of diseases, including cancer. Its involvement in the TGF-β pathway and its association with cellular processes that are involved in disease development make it an attractive target for manipulation.

One potential application of EXPH5 is as a cancer therapeutic. Cancer is a disease that is characterized by the uncontrolled growth and proliferation of cells. The TGF-β pathway is thought to play a key role in the regulation of cell growth and differentiation, and is involved in the development of cancer. By targeting EXPH5, researchers may be able to disrupt the regulation of cell growth and survival that is associated with cancer.

Another potential application of EXPH5 is as a biomarker for the diagnosis and prognosis of cancer. The TGF-β pathway is thought to be involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and survival. By analyzing the expression of EXPH5 in cancer cells, researchers may be able to identify new biomarkers for the diagnosis and prognosis of cancer.

EXPH5 is also potential target for drug development for other diseases. Its role in the regulation of cell survival and its association with the TGF-β pathway make it an attractive target for manipulation in a variety of diseases, including neurodegenerative disorders, autoimmune diseases, and inflammation.

Conclusion

EXPH5 is a protein that is expressed in various tissues of the human body and is involved in the regulation of cell growth and differentiation. Its association with the TGF-β pathway and its potential as a drug target or biomarker for a number of diseases make it an attractive target for manipulation. Further research is needed to fully understand the role of EXPH5 in disease and its potential as a therapeutic.

Protein Name: Exophilin 5

Functions: May act as Rab effector protein and play a role in vesicle trafficking

The "EXPH5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EXPH5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets